EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 updateJosef S Smolen, Désirée van der Heijde, Robert Landewé et al.|Annals of the Rheumatic Diseases|2022Cited by 1.9k
2022 updateJosef S Smolen, Josef S. Smolen, Robert Landewé et al.|Radboud Repository (Radboud University)|2010Cited by 1.6k
THU0212 FIRST LINE TREATMENT WITH CONVENTIONAL SYNTHETIC DISEASE MODIFYING ANTIRHEUMATIC DRUGS IN RHEUMATOID ARTHRITIS: A MULTINATIONAL POPULATION-BASED COHORT FROM 14 REAL WORLD HEALTHCARE DATABASES AND 9 COUNTRIES - REALITY VERSUS GUIDELINESAnthony G. Sena, Patrick Ryan, Sulev Reisberg et al.|Annals of the Rheumatic Diseases|2020Cited by 1